Answers are grounded in this paper and cite their sources.
No studies have reported simultaneous evaluation of the two coronary risk markers of testosterone and skin autofluorescence (SAF) as a marker of advanced glycation end products in patients with type 2 diabetes mellitus (T2DM) at present. This study aimed to clarify the clinical significance of both indicators as risk markers of coronary artery disease (CAD), including the association and background factors between testosterone and SAF in male patients with T2DM.
No takes yet. Share an insight, caveat, or question.
Takashi Hitsumoto (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: